These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14367297)

  • 21. [Character of the immune response in guinea pigs following immunization with brucellosis protective antigen].
    Shuvalov LP; Grekova NA; Vershilova PA
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):59-61. PubMed ID: 1015079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental studies on immunization with associated brucellosis-tularemia vaccine in guinea pigs].
    GUBINA EA
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Nov; 28(11):107-11. PubMed ID: 13544545
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of streptomycin-resistant and nonresistant strains for the determination of the immunizing effect of living Brucella abortus vaccines in white mice.
    OLITZKI AL; SULITZEANU D
    J Infect Dis; 1954; 94(3):213-24. PubMed ID: 13174837
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunization of guinea pigs through un-injured conjunctiva with live brucellosis vaccine NIIEG].
    SELIVANOV AV
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jul; 27(7):86-91. PubMed ID: 13353726
    [No Abstract]   [Full Text] [Related]  

  • 25. Active immunization with Brucella abortus S19 phage lysate elicits serum IgG that protects guinea pigs against virulent B. abortus and protects mice by passive immunization.
    Jain L; Rawat M; Ramakrishnan S; Kumar B
    Biologicals; 2017 Jan; 45():27-32. PubMed ID: 27913028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the scheme of vaccination on the resistance of guinea pigs to infection with brucellosis].
    Stepin VS; Grams IuF; Krushevskaia KF
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Apr; 46(4):109-13. PubMed ID: 4978127
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the immunizing power of Brucella in phase R of Buck 19 and Zdrodovsky BA strains].
    JACOTOT H; VALLEE A
    Ann Inst Pasteur (Paris); 1960 Mar; 98():360-6. PubMed ID: 14406452
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental studies on the mechanism of infection and immunity in tuberculosis from the standpoint of analysis of streptomycin dependent tubercle bacilli. 4. Immunization against tuberculosis in guinea pigs with a streptomycin-dependent mutant].
    HASHIMOTO T
    Kekkaku; 1955 Dec; 30(12):707-11. PubMed ID: 13307788
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunization of men by living attenuated brucellae].
    OLITZKI AL
    Harefuah; 1960 Jul; 59():37-8. PubMed ID: 14428656
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dynamics of immunobiologic reactions in guinea pigs immunized with the living vaccine against brucellosis in various states of the nervous system; preliminary communication].
    TUL'CHINSKAIA VP; FAITEL'BERG RO; APLIAK IV
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Jan; 1():23-7. PubMed ID: 13137498
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunization with viable Brucella organisms. Results of a safety test in humans.
    SPINK WW; HALL JW; FINSTAD J; MALLET E
    Bull World Health Organ; 1962; 26(3):409-19. PubMed ID: 13915813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BtaF Adhesin Is Necessary for Full Virulence During Respiratory Infection by
    Muñoz González F; Sycz G; Alonso Paiva IM; Linke D; Zorreguieta A; Baldi PC; Ferrero MC
    Front Immunol; 2019; 10():1775. PubMed ID: 31402921
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunization against brucella infection. II. Effectiveness of a streptomycin-dependent strain of brucella melitensis.
    HERZBERG M; ELBERG SS; MEYER KF
    J Bacteriol; 1953 Nov; 66(5):600-5. PubMed ID: 13108862
    [No Abstract]   [Full Text] [Related]  

  • 34. The immunization of guinea-pigs and mice with a whole-culture extract of a smooth and a rough strain of Brucella abortus.
    Keppie J; Witt K; Smith H
    Br J Exp Pathol; 1972 Oct; 53(5):518-28. PubMed ID: 4628447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenic properties of brucella protective antigen upon revaccination].
    Dranovskaia EA; Vershilova PA
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):94-9. PubMed ID: 828826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing biometric potency assays of brucella allergens in guinea-pigs.
    Jones LM; Berman DT; Diaz R
    Br J Exp Pathol; 1973 Aug; 54(4):368-79. PubMed ID: 4199238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cellular basis of immunity in experimental Brucella infection.
    HOLLAND JJ; PICKETT MJ
    J Exp Med; 1958 Sep; 108(3):343-60. PubMed ID: 13575671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brucella abortus antigen-induced lymphocyte reactivity in guinea pigs.
    Jones RL; Buening GM
    Vet Immunol Immunopathol; 1983 May; 4(4):433-43. PubMed ID: 6408788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ON THE CAUSE OF REDUCTION OF THE NATURAL RESISTANCE OF IRRADIATED ANIMALS TO LIVE BRUCELLOSIS VACCINE].
    SHEVTSOVA ZV
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Apr; 41():100-5. PubMed ID: 14221624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.